Brad Hoffman studies liver‑directed AAV gene transfer and immune modulation to induce antigen‑specific tolerance and restore immune balance. Work spans vector engineering and Treg‑modulating cell therapy for autoimmunity, hematologic disorders, and neuroinflammation.